Previous 10 | Next 10 |
Image source: The Motley Fool. Tandem Diabetes Care Inc (NASDAQ: TNDM) Q1 2020 Earnings Call Apr 30, 2020 , 4:30 p.m. ET Operator Continue reading
Tandem Diabetes Care, Inc. (TNDM) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Susan Morrison - Executive Vice President & Chief Administrative Officer John Sheridan - President & Chief Executive Officer Brian Hansen - Executive Vice Pre...
Tandem Diabetes Care (NASDAQ: TNDM ): Q1 GAAP EPS of -$0.25 misses by $0.08 . More news on: Tandem Diabetes Care, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Second Quarter 2020 Sales Guidance Provided, Annual Guidance Withdrawn Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2020. In addition, due to the unknown depth...
Growth has come easily for Tandem Diabetes Care (NASDAQ: TNDM) in recent years. The insulin pump developer grew revenue from $107 million in 2017 to $362 million in 2019. Margins have also improved as the business has scaled. Gross profit soared from $44 million to $194 million in that span,...
Bausch Health Companies (NYSE: BHC ) initiated with Buy rating and $30 (84% upside) price target at Citigroup. Shares up 1% premarket. More news on: Radius Health, Inc., Immunomedics, Inc., West Pharmaceutical Services, Inc., Healthcare stocks news, Stocks on the move, , Re...
Last month, Tandem Diabetes Care ( TNDM ) became one of the unexpected victims of the coronavirus pandemic. The stock fell from $60.21 on January 2 to $54.54 on March 23. The stock is already up and closed at $72.94 on April 17. While the company is up by 22.36% YTD (year-to-date), there is st...
After climbing by about 29% last year, the S&P 500 has slid by about 14% year to date as a result of the COVID-19 pandemic. However, some companies have largely escaped the recent sell-off and have performed well, even though the ongoing public health crisis has significantly slowed down e...
In the midst of the fallout from the coronavirus, it's difficult to envision a time when the outbreak is under control and life has returned to normal. But those days are coming. That said, consumerism may never quite be the same again, as working at home has proven viable for some, while others...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2020 results after the financial markets close on Thursday, April 30, 2020. The Company will hold a conference call and simultaneous webcast on the same da...
News, Short Squeeze, Breakout and More Instantly...
Tandem Diabetes Care Inc. Company Name:
TNDM Stock Symbol:
NASDAQ Market:
Tandem Diabetes Care Inc. Website:
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigat...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:...
2024-04-07 12:07:00 ET About a half-billion adults in the world have diabetes. This chronic health condition causes severe hardships to patients and contributes substantially to healthcare costs. It's no wonder that many companies continue developing innovative products to help diabetes...